XBiotech Enrolls Final Patient in Phase I Portion of Clinical Study of … – GlobeNewswire (press release)
XBiotech Enrolls Final Patient in Phase I Portion of Clinical Study of …GlobeNewswire (press release)AUSTIN, Texas, March 09, 2016 (GLOBE NEWSWIRE) — XBiotech (NASDAQ:XBIT) announced today completion of enrollment in the Phase I portion of the …